OPRC_Banner_Logo

ALERT BAR

Dates


Publications


Publications

  • Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: A randomized placebo-controlled trial

    Koren, G., Clark, S. M., Hankins, G. D. V., Caritis, S. N., Miodovnik, M., & Mattison, D. R. (2010). Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: A randomized placebo-controlled trial. American Journal of Obstetrics and Gynecology, 203(6), 571.e1-571.e7. doi: 10.1016/j.ajog.2010.07.030. (PMID: 20843504)
  • Atenolol Pharmacokinetics and excretion in breast milk during the first 6-8 months postpartum

    Eyal, S., Kim, J. D., Anderson, G. D., Buchanan, M. L., Brateng, D. A., Carr, D., Woodrum, D. E., Easterling, T. R., & Hebert, M. F. (2010). Atenolol Pharmacokinetics and excretion in breast milk during the first 6-8 months postpartum. Journal of Clinical Pharmacology, 50(11), 1301-1309. doi: 10.1177/0091270009358708. (PMID: 20145263)
  • Pharmacodynamics of clonidine therapy in pregnancy: A heterogeneous maternal response impacts fetal growth

    Rothenberger, S., Carr, D., Brateng, D., Hebert, M., & Easterling, T. (2010). Pharmacodynamics of clonidine therapy in pregnancy: A heterogeneous maternal response impacts fetal growth. American Journal of Hypertension, 23, 1234-1240. doi: 10.1038/ajh.2010.159. (PMID: 20725050)
  • Maternal serum folate species in early pregnancy and risk of preterm birth

    Bodnar, L. M., Himes, K. P., Venkataramanan, R., Chen, J. Y., Evans, R. W., Meyer, J. L., & Simhan, H. N. (2010). Maternal serum folate species in early pregnancy and risk of preterm birth. American Journal of Clinical Nutrition, 92(4), 864-871. doi: 10.3945/ajcn.2010.29675. (PMID: 20739422)
  • CYP2D6 mediates 4-hydroxylation of clonidine in vitro: Implication for pregnancy-induced changes in clonidine clearance

    Claessens, A., Risler, L., Eyal, S., Shen, D., Easterling, T., & Hebert, M. (2010). CYP2D6 mediates 4-hydroxylation of clonidine in vitro: Implication for pregnancy-induced changes in clonidine clearance. Drug Metabolism and Disposition, 38(9), 1393-1396. doi: 10.1124/dmd.110.033878. (PMID: 20570945)
  • Increased Glyburide Clearance in the Pregnant Mouse Model

    Zhou, L., Zhang, Y., Hebert, M., Unadkat, J., & Mao, Q. (2010). Increased Glyburide Clearance in the Pregnant Mouse Model. Drug Metabolism and Disposition, 38(9), 1403-1406. doi: 10.1124/dmd.110.033837. (PMID: 20558597)
  • Pharmacokinetics of Metformin during pregnancy

    Eyal, S., Easterling, T. R., Carr, D., Umans, J. G., Miodovnik, M., Hankins, G. D., Clark, S. M., Risler, L., Wang, J., Kelly, E. J., Shen, D. D., & Hebert, M. F. (2010). Pharmacokinetics of Metformin during pregnancy. Drug Metabolism and Disposition, 38, 833-840. doi: 10.1124/dmd.109.031245. (PMID: 20118196)
  • Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes

    Sharma, S., Ellis, E. C., Dorko, K., Zhang, S., Mattison, D. R., Caritis, S. N., Venkataramanan, R., & Strom, S. C. (2010). Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes. Drug Metabolism and Disposition, 38(5), 723-727. doi: 10.1124/dmd.109.029918. (PMID: 20097724)
  • Contributions of human cytochrome P450 enzymes to Glyburide metabolism

    Zhou, L., Naraharisetti, S. B., Liu, L., Wang, H., Lin, Y. S., Isoherranen, N., Unadkat, J. D., Hebert, M. F., & Mao, Q. (2010). Contributions of human cytochrome P450 enzymes to Glyburide metabolism. Biopharmaceutics and Drug Disposition, 31(4), 228-242. doi: 10.1002/bdd.706. (PMID: 20437462)
  • Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin

    Hemauer, S. J., Patrikeeva, S. L., Nanovskaya, T. N., Hankins, G. D., & Ahmed, M. S. (2010). Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. American Journal of Obstetrics and Gynecology, 202(4), 383.e1-383.e7. doi: 10.1016/j.ajog.2010.01.035. (PMID: 20350646)
  • Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms

    Hemauer, S. J., Nanovskaya, T. N., Abdel-Rahman, S. Z., Patrikeeva, S. L., Hankins, G. D., & Ahmed, M. S. (2010). Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms. Biochemical Pharmacology, 79(6), 921-925. doi: 10.1016/j.bcp.2009.10.026. (PMID: 19896927)
  • Positron emission tomography imaging of tissue P-glycoprotein during pregnancy in the non-human primate

    Chung, F. S., Eyal, S., Muzi, M., Link, J. M., Mankoff, D. A., Kaddoumi, A., O’Sullivan, F., Hsiao, P., & Unadkat, J. D. (2010). Positron emission tomography imaging of tissue P-glycoprotein during pregnancy in the non-human primate. British Journal of Pharmacology, 159(2), 394-404. doi: 10.1111/j.1476-5381.2009.00538.x. (PMID: 20002098)
  • Biotransformation of medications by human placenta

    Zharikova, O. L., Nanovskaya, T. N., & Ahmed, M. S. (2010). Biotransformation of medications by human placenta. In S. J. Yaffe & J. V. Aranda (Eds.), Neonatal and Pediatric Pharmacology; Therapeutic Principles in Practice, 4th Edition (pp. 144-153). Philadelphia, PA: Lippincott Williams & Wilkins.